A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

NCT05051579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight and Obesity

Interventions

DRUG: LY3502970
DRUG: Placebo

Sponsor

Eli Lilly and Company